课题基金 / 基金详情

DEVELOPMENTAL & FUNCTIONAL ROLES OF ACTIVIN & INHIBIN

DEVELOPMENTAL & FUNCTIONAL ROLES OF ACTIVIN & INHIBIN
发展型
批准号:
3087089
负责人:
MARTIN M. MATZUK
金额:
$6.64万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1991
资助国家:
美国
项目状态:
已结题
起止时间:
1991-08-01 至 1996-07-31

项目摘要

项目成果

MARTIN M. MATZUK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Activin and inhibin are members of a large family of dimeric growth factors which also includes Mullerian inhibiting substance (MIS), and several transforming growth factor beta's (TGF-beta's)(1-16). Activin is a homodimeric beta:beta protein and inhibin is a heterodimeric alpha:beta protein with the beta subunit (either betaA or betaB activin) common to the two proteins (1-3). Both activin and inhibin, similar to the other growth factors in this family, have been postulated to be important in a number of differentiation and developmental events (1-3, 20-22, 25, 26). The goal of this project is to understand the developmental and physiological roles of inhibin and activin. These studies will address whether activin is physiologically important as a mesoderm inducing factor in mammals, whether each of the activin beta subunits have different developmental roles, especially in brain development, and whether activin and inhibin play important paracrine, autocrine, and endocrine functions in pituitary and gonadal development. In phase I of this project, the aims are: 1) Clone and characterize the mouse alpha inhibin, betaA activin, and betaB activin genes; 2) Construct vectors from these mouse genes for use in homologous recombination experiments and generation of embryonic stem cell lines with mutations at these loci; 3) Produce mice which are homozygous and heterozygous for these mutant alleles; and 4) Analyze the morphologic, histologic, and biochemical consequences of mutations at the a inhibin, betaA activin and betaB activin loci to address the roles of activin and inhibin in the above-mentioned developmental processes. Phase II of this project involves: 1) Further morphologic, histologic, and biochemical characterization of the mutant mice produced in phase I; and 2) Crossbreeding of mice carrying these different mutant alleles in their germlines to produce mice deficient in several of the activins and inhibins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Kinases as Therapeutic Targets for Endometriosis
  • 批准号:
    10674987
  • 项目类别:
  • 资助金额:
    $68.77万
  • 财政年份:
    2022
  • 负责人:
    MARTIN M. MATZUK
  • 依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
  • 批准号:
    10682061
  • 项目类别:
  • 资助金额:
    $64.52万
  • 财政年份:
    2022
  • 负责人:
    MARTIN M. MATZUK
  • 依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
  • 批准号:
    10764639
  • 项目类别:
  • 资助金额:
    $4.84万
  • 财政年份:
    2022
  • 负责人:
    MARTIN M. MATZUK
  • 依托单位:
Disruption of semen liquefaction using specific KLK3 inhibitors as a new contraceptive
  • 批准号:
    10419647
  • 项目类别:
  • 资助金额:
    $10.15万
  • 财政年份:
    2022
  • 负责人:
    MARTIN M. MATZUK
  • 依托单位:
国内基金
海外基金
Sitagliptin通过microbiota-gut-brain轴在2型糖尿病致阿尔茨海默样变中的脑保护作用机制
  • 批准号:
    81801389
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    21.0万元
  • 批准年份:
    2018
  • 负责人:
    田茗源
  • 依托单位:
平扫描数据导引的超低剂量Brain-PCT成像新方法研究
  • 批准号:
    81101046
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    23.0万元
  • 批准年份:
    2011
  • 负责人:
    黄静
  • 依托单位: